Validation of the ONKOTEV Risk Prediction Model for Venous Thromboembolism in Outpatients With Cancer.

ABSTRACT:

Importance

The assessment of the risk of venous thromboembolism (VTE) among outpatients with cancer represents an unsolved topic. Current international guidelines recommend primary prophylaxis for patients at intermediate to high risk of VTE, indicated by a Khorana score of 2 or more. A previous prospective study developed the ONKOTEV score, a 4-variable risk assessment model (RAM) consisting of a Khorana score of more than 2, metastatic disease, vascular or lymphatic compression, and previous VTE event.

Objective

To validate the ONKOTEV score as a novel RAM to assess the risk of VTE among outpatients with cancer.

Design, setting, and participants

ONKOTEV-2 is a noninterventional prognostic study conducted in 3 European centers located in Italy, Germany, and the Unite

SUBMITTER: Cella CA 

PROVIDER: S-EPMC9936336 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature